Orum Therapeutics is an oncology-focused biotech company pioneering the development of antibody-enabled, dual-precision targeted protein homeostasis. We leverage our TPD² approach to provide targeted protein degraders, and TPS² approach to provide targeted protein stabilizers for cell-specific delivery to improve patient outcomes. Orum is located in Lexington, MA, USA and Daejeon, South Korea.
Company Details
- Employees
- 55
- Founded
- -
- Address
- 1050 Waltham St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- orumrx.com
- Keywords
- Biotechnology, TPD, Targeted protein degradation, Oncology, Cancer, Antibody drug conjugation, ADC, Drug Development.
- HQ
- Lexington, Massachusetts
Orum Therapeutics Questions
Orum Therapeutics's website is orumrx.com
Orum Therapeutics's LinkedIn profile is https://www.linkedin.com/company/orum-therapeutics
Orum Therapeutics has
55 employees.
View email and phone details for 55
employees at Orum Therapeutics.
Orum Therapeutics's industry is
Biotechnology Research
Orum Therapeutics's top competitors are
Vertex Pharmaceuticals,
Bonito Biosciences,
Kymera Therapeutics,
Lassen Therapeutics,
Tesseract Medicines,
Beam Therapeutics,
Orna Therapeutics,
Tscan Therapeutics,
Prelude Therapeutics,
Relay Therapeutics.
Orum Therapeutics's categories are Biotechnology Research
Orum Therapeutics's founding year is 2016
